http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
BioLife Solutions Announces Preliminary First Quarter 2020 Revenue
-
BioLife Solutions Announces Fourth Quarter and Full Year 2019 Financial Results
-
BioLife Solutions Awarded Three New Patents for Cell and Gene Therapy Bioproduction Tools
-
BioLife Solutions Announces Earnings Call Date and Upcoming Investor and Scientific Conferences
-
BioLife Solutions Announces Executive Appointments to Support Integration of Acquired Companies
-
BioLife Solutions (BLFS) Acquires Custom Biogenic Systems
-
BioLife Solutions Acquires Custom Biogenic Systems
-
BioLife Solutions Announces Third Quarter 2019 Financial Results
-
BioLife Solutions Named one of the Fastest Growing Companies in North America on Deloitte's 2019 Technology Fast 500™
-
BioLife Solutions to Report Third Quarter 2019 Financial Results and Provide Business Update on November 12, 2019
-
BioLife Solutions Awarded Three New Patents for Cryopreservation, Thawing and Cold Chain Transport Technologies
-
BioLife Solutions Announces Cell and Gene Therapy Bioproduction Innovation Accelerator
-
iVexSol Announces $2M in Seed Funding
-
BioLife Solutions Announces New evo® Cold Chain Customers
-
Mustang Bio Adopts CryoStor® Freeze Media and evo® Cold Chain System for Cell and Gene Therapy Manufacturing and Distribution
-
BioLife Solutions Strengthens Sales Team with Key Leadership Additions
-
BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences
-
BioLife Solutions Announces Second Quarter 2019 Financial Results
-
BioLife Solutions Completes Acquisition of SAVSU Technologies
-
BioLife Solutions to Report Second Quarter 2019 Financial Results and Provide Business Update on August 8, 2019
-
SAVSU Technologies Expands IP Portfolio with Risk Mitigation Technologies for Shipping Cell and Gene Therapies
-
SAVSU Technologies Partners with United Cargo® to Improve Cold Chain Management and Delivery of Cell and Gene Therapies
-
BioLife Solutions (BLFS) to Acquire SAVSU Technologies
-
BioLife Solutions to Acquire SAVSU Technologies
-
BioLife Solutions to Join Russell 3000® Index
-
BioLife Solutions to Present at the Jefferies 2019 Healthcare Conference
-
BioLife Solutions Announces SAVSU Technologies Selected by Novartis to Supply Advanced Cold Chain Management Platform for Newly Approved Gene Therapy
-
BioLife Solutions Announces First Quarter 2019 Financial Results
-
BioLife Solutions to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019
-
BioLife Solutions Announces Fourth Quarter and Full Year 2018 Financial Results
-
BioLife Solutions to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on March 14, 2019
-
BioLife Solutions to Attend and Present at Upcoming Investor and Scientific Conferences
-
New Policies to Advance Development of Cell and Gene Therapies Announced by FDA
-
BioLife Solutions Completes Redemption of Series A Preferred Stock
-
BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences
-
BioLife Solutions Announces Third Quarter 2018 Financial Results
-
BioLife Solutions to Report Third Quarter 2018 Financial Results and Provide Business Update on November 8, 2018
-
BioLife Solutions Reports Record Third Quarter 2018 Preliminary Revenue of $5.3 Million, up 79% Year-over-Year
-
BioLife Solutions Increases Ownership in SAVSU Technologies to 44% with $5 Million Investment
-
BioLife Solutions to Ring NASDAQ Closing Bell on August 29, 2018
-
BioLife Solutions Announces Second Quarter 2018 Financial Results
-
Casdin Capital Invests $20 Million in BioLife Solutions to Support Strategic Growth Opportunities
-
BioLife Solutions to Present and Exhibit at Fall Investor and Cell & Gene Therapy Conferences
-
BioLife Solutions to Report Second Quarter 2018 Financial Results and Provide Business Update on August 9, 2018
-
Sandler Capital Funds to Increase Shareholding in BioLife Solutions
-
BioLife Solutions Reports Second Quarter 2018 Preliminary Revenue of $5.2 Million, up 103% Year-over-Year and 36% Sequentially
-
BioLife Solutions to Join Russell Microcap® Index
-
BioLife Solutions to Present at the 2018 BIO International Convention
-
BioLife Solutions Announces Partial Redemption of Series A Preferred Stock
-
BioLife Solutions Makes Investment in SAVSU Technologies to Support Growth and Capture Additional Regenerative Medicine Cold Chain Opportunities

